Table 2.
Study outcomes
| Parameter | Control | Group A | Group B |
| Total units transfused | 138 | 33* | 23* |
| % of transfused patients | 58.3 | 37.3* | 26.5* |
| Units transfused per patient | 2.83 ± 3.9 | 0.64 ± 1.0* | 0.47 ± 0.9* |
| Units transfused per transfused patient | 4.86 ± 4.0 | 1.74 ± 0.7* | 1.77 ± 0.7* |
| Volume of RBCs transfused per day | 43.2 ± 61.1 | 11.3 ± 20.3* | 16.1 ± 36.1* |
| Average days transfused | 1.60 ± 2.2 | 0.59 ± 0.9* | 0.35 ± 0.7* |
| Hct (%) at day 28 | 30.4 ± 4.5 | 33.3 ± 5.3* | 37.5 ± 5.8* † |
| Hb (mg/dl) at day 28 | 9.9 ± 1.5 | 10.7 ± 1.9 | 11.6 ± 1.9* |
| ΔHct (%) | 2.09 ± 5.0 | 5.53 ± 5.5* | 8.76 ± 6.2* † |
| ΔHb (mg/dl) | 0.69 ± 1.5 | 1.43 ± 1.7 | 2.24 ± 6.2* |
*P < 0.05 versus control; †P < 0.05 versus group A. ΔHb, mean increase in Hb from baseline to final measurement; ΔHct, mean increase in Hct from baseline to final measurement; Hb, haemoglobin; Hct, haematocrit; RBC, red blood cell.